Chemed (CHE) Aandeel Koers
Chemed Koers
De omzet is de afgelopen 19 jaar met 4,9% per jaar gegroeid tot 2,53 Miljard USD. De winst per aandeel is de afgelopen 19 jaar met 12,7% per jaar gegroeid. De nettowinstmarge van Chemed ligt op 10,5% en is ten opzichte van 12,6% enkele jaren eerder gedaald. Chemed biedt momenteel een dividendrendement van circa 0,40%. De uitkeringsratio ligt rond 12% van de winst. Het dividend is de afgelopen 19 jaar met 12,4% per jaar gegroeid. Analisten hanteren een mediaan koersdoel van 554,00 USD — dat impliceert 1,1% boven de huidige koers. Van de 9 analisten geven 6 het aandeel een koopadvies — per saldo een Kopen-consensus.
Chemed aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Chemed bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Chemed
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed Corp is primarily active in the healthcare and service industries.
The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.
Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.
Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.
Chemed Corp is primarily present in the United States.
Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.
Analisten hanteren momenteel een gemiddeld koersdoel van 554,00 USD voor het aandeel Chemed (mediaan: 554,00 USD), oftewel +1,1 % ten opzichte van de laatste koers. De consensus is gebaseerd op 9 analistenratings.
9 analisten beoordelen het aandeel Chemed momenteel: 6 adviseren kopen, 3 houden en 0 verkopen. Voor 2026 verwachten analisten dat Chemed een omzet van 2,73 Miljard USD en winst per aandeel van 27,97 USD behaalt.
Omgezet tegen de huidige wisselkoers noteert het aandeel Chemed op 496,66 EUR (548,20 USD).
Het aandeel Chemed (CHE) is genoteerd aan 2 beurzen, waaronder: NYSE (CHE), Frankfurt (CXM.F).
Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.
De verwachte omzet van Chemed bedraagt 2,73 Miljard USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van Chemed bedraagt 391,42 Miljoen USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Chemed bedraagt momenteel 19,60. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Chemed-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Chemed bedraagt momenteel 2,81. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Chemed-aandeel.
De Eulerpool Kwaliteitsscore voor Chemed is 8/10.
De ISIN van Chemed is US16359R1032. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Chemed is A0CBF4. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Chemed is CHE. Onder dit beurstickersymbool wordt het Chemed-aandeel op de beurs verhandeld.
Chemed aandeel
Chemed Peer Group
Chemed Ticker
Chemed FIGI
Alle fundamentals en diepgaande analyse van Chemed
Onze aandelenanalyse van het Chemed-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Chemed. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: